Hopp til innhold
NHI.no
Annonse

Mykoplasma lungebetennelse: Behandling

Innhold i artikkelen

De fleste infeksjoner med Mycoplasma pneumoniae har et mildt forløp og krever ikke antibiotikabehandling. Ved påvist mykoplasmainfeksjon er det bare behov for antibiotika ved sterk mistanke om lungebetennelse. Ved høy feber og klare tegn på lungebetennelse kan antibiotika forkorte sykdomsperioden og den smittsomme perioden. Dersom det skal gis antibiotika anbefales erytromycin eller doksysyklin i 7-10 døgn. Vanlig penicillin hjelper som nevnt ikke mot denne bakterien.

Annonse

Bare unntaksvis er det påkrevd med sykehusinnleggelse for Mykoplasma lungebetennelse.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Mykoplasmapneumoni . Referanselisten for dette dokumentet vises nedenfor

  1. Thibodeau KP, Viera AJ. Atypical pathogens and challenges in community-acquired pneumonia. Am Fam Physician 2004; 69: 1699-706. PubMed
  2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17: 697-728. PubMed
  3. Nir-Paz R. Mycoplasma infection. BMJ Best Practice, last reviewed July 2020. bestpractice.bmj.com
  4. Baum SG. Mycoplasma pneumoniae infection in adults. UpToDate, last updated Jan 23, 2020. Siden besøkt 31.08.2020. www.uptodate.com
  5. Chalker V, Stocki T, Litt D, et al. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012;17:pii:20081.
  6. Pereyre S, Charron A, Hidalgo-Grass C, et al. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One. 2012;7:38585. PubMed
  7. Vallejo JG. Mycoplasma pneumoniae infection in children. UpToDate, last updated Jul 18, 2018. www.uptodate.com
  8. Kannan TR, Provenzano D, Wright JR, Baseman JB. Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun. 2005; 73: 2828-34. PubMed
  9. Falguera M, Sacristan O, Nogues A, et al. Non-severe community-acquired pneumonia: correlation between cause and severity or comorbidity. Arch Int Med 2001; 161: 1866-87. PubMed
  10. Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD009175. DOI: 10.1002/14651858.CD009175.pub2. DOI
  11. Smittevernveilederen. Mycoplasma pneumoniae-infeksjoner - veileder for helsepersonell. Folkehelseinstituttet, sist oppdatert 23.02.2019. fhi.no
  12. Waites KB. Mycoplasma infections (Mycoplasma pneumoniae), clinical presentation. Medscape Jul 24, 2017. emedicine.medscape.com
  13. Walter ND, Grant GB, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis 2008; 198: 1365-74. PubMed
  14. Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect. 2006; 12 Suppl 3:12-24.
  15. Loens K, Ieven M. Mycoplasma pneumoniae: Current Knowledge on Nucleic Acid Amplification Techniques and Serological Diagnostics. Front Microbiol 2016; 7: 448. pmid:27064893 PubMed
  16. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015 Jan 8;1:CD004875. DOI: 10.1002/14651858.CD004875.pub5 DOI
  17. Melbye H, Kulosman D. Pneumoni. Lindbæk M (red). Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Oslo: Antibiotikasenteret for primærhelsetjenesten og Helsedirektoratet, sist oppdatert 08.11.2016. www.antibiotikaiallmennpraksis.no
Annonse
Annonse